Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    Olanzapine induced neuroleptic malignant syndrome, treated with electroconvulsive therapy (ECT)-A case report.

    Asian J Psychiatr 2017 Dec 14;30:230-231. Epub 2017 Jul 14.
    NIMHANS, Bengaluru, India; Professor of Psychiatry and I/C Head of Psychiatric Rehabilitation Services, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru 560029, India; NIMHANS, Bengaluru, India. Electronic address:
    PDF Download - Full Text Link
    ( Please be advised that this article is hosted on an external website not affiliated with
    Source Status ListingPossible

    Similar Publications

    Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases.
    Aust N Z J Psychiatry 1999 Oct;33(5):650-9
    Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, New South Wales, Australia.
    Objective: Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse effect of neuroleptic medication, with no satisfactory treatment currently available. Electroconvulsive therapy (ECT) has been anecdotally reported to be effective in its treatment. We review 45 published case reports of ECT for NMS and describe nine new cases, to examine its effectiveness, the likelihood of adverse reactions, and the theoretical implications of such treatment. Read More
    Neuroleptic Malignant Syndrome: Neuroleptic Rechallenge After Electroconvulsive Therapy.
    Convuls Ther 1993 ;9(3):198-204
    Eitanim Psychiatric Hospital and Hebrew University Hadassah Medical School, Jerusalem, Israel.
    The necessity of neuroleptic rechallenge in patients who have experienced neuroleptic malignant syndrome (NMS) has been discussed in recent articles. Electroconvulsive therapy (ECT) has been proposed as an alternative treatment to neuroleptics. In cases where ECT fails, neuroleptic rechallenge remains the only alternative. Read More
    Successful treatment of hydroxyzine and dexclorfeniramine maleate in combination with electroconvulsive therapy in a neuroleptic malignant catatonia: a case report.
    Int Clin Psychopharmacol 2015 Mar;30(2):115-7
    aHospital Benito Menni CASM, Dr Antoni Pujadas bFIDMAG Germanes Hospitalàries Research Foundation, CIBERSAM, Barcelona, Spain.
    Malign neuroleptic syndrome is a potentially life-threatening condition that is normally treated with electroconvulsive therapy (ECT). In this case report, we discuss a severely agitated and catatonic bipolar I patient who developed a neuroleptic malignant syndrome and did not improve with benzodiazepines and ECT. On the basis of anecdotal reports of the positive effects of antihistamines in psychosis and ECT, we treated our case with a combination of two antihistamines, hydroxyzine and dexclorfeniramine maleate, and ECT, which improved the clinical picture to the point of clinical remission. Read More